Robotic anti-reflux surgery rapidly relieves GERD symptoms long-term.

Robotic anti-reflux surgery (ARS) delivers significant relief for both typical and atypical gastroesophageal reflux disease (GERD) symptoms. Within three months, 90% of patients reported major improvements in regurgitation, heartburn, and belching. Atypical symptoms, such as cough and throat clearing, improved more slowly but showed notable reductions after a year. Key factors influencing outcomes vary, underscoring the need for personalized surgical strategies based on symptom profiles and preoperative assessments.